Literature DB >> 8094189

Differential response in a patient treated with Campath-1H monoclonal antibody for refractory non-Hodgkin lymphoma.

S H Lim, G Davey, R Marcus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8094189     DOI： 10.1016/0140-6736(93)93024-u

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Serum lipids and mood in working men and women in Sweden.

Authors:  G Lindberg; G Larsson; S Setterlind; L Råstam
Journal:  J Epidemiol Community Health       Date:  1994-08       Impact factor: 3.710

2.  Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia: a history and discussion of future rational use.

Authors:  Jeremy L Warner; Jon E Arnason
Journal:  Ther Adv Hematol       Date:  2012-12

Review 3.  Alemtuzumab in T-cell malignancies.

Authors:  Claire E Dearden; Estella Matutes; Daniel Catovsky
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.